Laboratory technique for visualization and analysis of chromosomes in metaphase cells to determine number, size, shape, and banding pattern.
Produces a karyogram, a digital representation organizing the entire genome’s paired chromosomes.
Chromosomes are classified based on length (chromosome 1 is longest, 22 is smallest), banding pattern, and centromere position (metacentric, submetacentric, or acrocentric).
Standard resolution is 5-10 Megabases (Mb), allowing detection of numerical abnormalities (aneuploidies) and large structural rearrangements.
Methodology And Procedure
Sample Collection: Requires actively dividing cells sourced from peripheral blood lymphocytes, skin fibroblasts, bone marrow aspirates, chorionic villi, or amniotic fluid.
Cell Culture: Phytohemagglutinin (PHA) stimulation is utilized for T-lymphocytes over 72 hours.
Mitotic Arrest: Colchicine or colcemid is added to block spindle formation, arresting cells in metaphase or prometaphase.
Hypotonic Treatment: Swells cells and disrupts the nuclear membrane, facilitating proper dispersion of chromosomes on the slide.
Fixation: Utilizes a methanol and acetic acid mixture.
Banding And Staining: GTG banding (G bands by trypsin using Giemsa) is the most widely utilized method, producing a unique sequence of dark (G-positive) and light (G-negative) bands.
Microscopic Analysis: Standard metaphase spread provides 450-550 bands. High-resolution analysis utilizes less-condensed prometaphase chromosomes, yielding 550-850 bands. A minimum of 20-30 metaphases are analyzed to detect mosaicism.
Clinical Indications
Category
Specific Indications
Suspected Aneuploidy Syndromes
Clinical features of Down syndrome (Trisomy 21), Edwards syndrome (Trisomy 18), Patau syndrome (Trisomy 13), Turner syndrome (45,X), or Klinefelter syndrome (47,XXY).
Pediatric And Developmental
Multiple congenital anomalies, dysmorphic features, unexplained global developmental delay or intellectual disability.
Reproductive And Endocrine
Ambiguous genitalia, disorders of sexual differentiation, primary amenorrhea, and infertility.
Family History
Recurrent pregnancy losses (≥ 3), history of stillbirths/neonatal deaths, or family history of balanced structural chromosomal rearrangements.
Oncology
Surveillance for specific solid tumors and leukemias (e.g., Philadelphia chromosome) via bone marrow aspirates.